Myoneurin pseudogene

The myoneurin pseudogene (LOC100129923, ENSG00000258906) is a non-coding sequence similar to the myoneurin (MYNN) gene but is classified as a *pseudogene*, lacking the ability to code for a functional protein. Pseudogenes are generally regarded as non-functional remnants of gene duplication or retrotransposition events; however, scientific advances demonstrate that some pseudogenes may exert biological impact at the RNA level, including possible regulatory roles by acting as endogenous RNA competitors or miRNA sponges, which may influence the expression of coding genes with sequence homology[2][4][5].\nThere is no evidence that the myoneurin pseudogene encodes a receptor, enzyme, transporter, or other druggable protein. It is not a direct therapeutic target, nor is it associated with any known biomarkers, interacting drugs, or established safety concerns. While research suggests that some pseudogenes can play roles in cancer, immune response, or other pathways by regulating gene expression post-transcriptionally (e.g., via siRNA or ceRNA mechanisms), there are no reports detailing such a function or disease linkage for the myoneurin pseudogene specifically[2][4][5].\nIts designation as a pseudogene marks it as distinct from the protein-coding MYNN gene (myoneurin), which itself is involved in transcriptional regulation and diverse signaling pathways[3], but LOC100129923 does not produce a known protein product nor serve as a classic drug target.

Other names

LOC100129923ENSG00000258906